UPDATE: Raymond James Downgrades Voyager Therapeutics (VYGR) to Outperform

Go back to UPDATE: Raymond James Downgrades Voyager Therapeutics (VYGR) to Outperform

Wells Fargo Downgrades Voyager Therapeutics (VYGR) to Equal Weight

November 10, 2020 4:35 AM EST

Wells Fargo analyst Jim Birchenough downgraded Voyager Therapeutics (NASDAQ: VYGR) from Overweight to Equal Weight with a price target of $10.00.


For an analyst ratings summary and ratings history on Voyager Therapeutics click here. For more ratings news on Voyager Therapeutics click here.


Shares of Voyager Therapeutics closed at $11.20 yesterday.

... More